News

Hosted on MSN3d
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders Wary
Eli Lilly and Co's obesity drug Zepbound led to greater weight loss than Novo Nordisk's Wegovy in a head-to-head Phase 3b ...
KDFW2d
Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial
A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that ...
Nasdaq3d
Lilly's Zepbound Outperforms Wegovy In Phase 3b Trial For Weight Reduction
(RTTNews) - Eli Lilly and Co. (LLY) announced that Zepbound (tirzepatide) demonstrated a significantly greater weight reduction compared to Wegovy (semaglutide) in all comparisons conducted during ...
Devdiscourse2d
Trump’s Bold Move: Prescription Drug Price Slash
President Trump announced an executive order to significantly reduce U.S. drug prices, aiming to align with costs in other ...